相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic polymorphisms of organic cation transporter 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes A systematic review
Edith Pascale Mofo Mato et al.
MEDICINE (2018)
Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease
Elena Barengolts et al.
PLOS ONE (2018)
Improved glycemic control with minimal systemic metformin exposure: Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetes
Robert R. Henry et al.
PLOS ONE (2018)
Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut
Jacobo de la Cuesta-Zuluaga et al.
DIABETES CARE (2017)
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
Hao Wu et al.
NATURE MEDICINE (2017)
Drug Interactions of Metformin Involving Drug Transporter Proteins
Naina Mohamed Pakkir Maideen et al.
ADVANCED PHARMACEUTICAL BULLETIN (2017)
The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities
Louise Brunkwall et al.
DIABETOLOGIA (2017)
Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5
John B. Buse et al.
DIABETES CARE (2016)
Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials
Ralph A. DeFronzo et al.
DIABETOLOGIA (2016)
Metformin and the gastrointestinal tract
Laura J. McCreight et al.
DIABETOLOGIA (2016)
Human gut microbes impact host serum metabolome and insulin sensitivity
Helle Krogh Pedersen et al.
NATURE (2016)
Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome
Rachel J. Perry et al.
NATURE (2016)
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Ron Sender et al.
PLOS BIOLOGY (2016)
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
Kristoffer Forslund et al.
NATURE (2015)
Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats
Frank A. Duca et al.
NATURE MEDICINE (2015)
Effect of Metformin on Metabolic Improvement and Gut Microbiota
Heetae Lee et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2014)
An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice
Na-Ri Shin et al.
GUT (2014)
Microbiota and diabetes: an evolving relationship
Herbert Tilg et al.
GUT (2014)
Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus
Antonella Napolitano et al.
PLOS ONE (2014)
The Role of Metformin in Metformin-Associated Lactic Acidosis (MALA): Case Series and Formulation of a Model of Pathogenesis
Janna K. Duong et al.
DRUG SAFETY (2013)
Gut metagenome in European women with normal, impaired and diabetic glucose control
Fredrik H. Karlsson et al.
NATURE (2013)
Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance
Xiuying Zhang et al.
PLOS ONE (2013)
A metagenome-wide association study of gut microbiota in type 2 diabetes
Junjie Qin et al.
NATURE (2012)
Metformin pathways: pharmacokinetics and pharmacodynamics
Li Gong et al.
PHARMACOGENETICS AND GENOMICS (2012)
Comparison of some of the physicochemical characteristics of type 2 diabetic and normal human bones: a sample study
Santhanam Sekar et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2011)
SLC22A2 gene 808 G/T variant is related to plasma lactate concentration in Chinese type 2 diabetics treated with metformin
Qing Li et al.
ACTA PHARMACOLOGICA SINICA (2010)
Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Nadja Larsen et al.
PLOS ONE (2010)
α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population
Walter E. Gall et al.
PLOS ONE (2010)
Metformin and the intestine
C. J. Bailey et al.
DIABETOLOGIA (2008)
Metagenomic analysis of the human distal gut microbiome
Steven R. Gill et al.
SCIENCE (2006)
Androgen receptor is responsible for rat organic cation transporter 2 gene regulation but not for rOCT1 and rOCT3
J Asaka et al.
PHARMACEUTICAL RESEARCH (2006)
Host-bacterial mutualism in the human intestine
F Bäckhed et al.
SCIENCE (2005)
Estimating the contribution of genes and environment to variation in renal drug clearance
MK Leabman et al.
PHARMACOGENETICS (2003)
Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2)
MJ Dresser et al.
PHARMACEUTICAL RESEARCH (2002)
Hormonal regulation of organic cation transporter OCT2 expression in rat kidney
Y Urakami et al.
FEBS LETTERS (2000)
分享论文
